| [1] |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med, 2019, 380(18):1695-1705.
|
| [2] |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med, 2019, 380(18):1706-1715.
|
| [3] |
Fassa AA, Himbert D, Vahanian A. Mechanisms and management of TAVR-related complications[J]. Nat Rev Cardiol, 2013, 10(12):685-695.
|
| [4] |
Rouleau SG, Brady WJ, Koyfman A, et al. Transcatheter aortic valve replacement complications: a narrative review for emergency clinicians[J]. Am J Emerg Med, 2022, 56:77-86.
|
| [5] |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632.
|
| [6] |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020更新版)[J]. 中国介入心脏病学杂志, 2020, 28(6):301-309.
|
| [7] |
Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature[J]. J Am Coll Cardiol, 2013, 61(15):1585-1595.
|
| [8] |
Sammour Y, Krishnaswamy A, Kumar A, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2021, 14(2):115-134.
|